West-ward 3189 (Lithium 300 mg)

Pill imprint West-ward 3189 has been identified as Lithium carbonate 300 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; depression; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for West-ward 3189

Lithium carbonate 300 mg West-ward 3189
Lithium carbonate
Imprint:
West-ward
3189
Strength:
300 mg
Color:
Gray & Yellow
Size:
20.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
West-Ward Pharmaceutical Corporation
National Drug Code (NDC):
00143-3189
Inactive Ingredients:
magnesium silicate
gelatin
titanium dioxide
butyl alcohol
propylene glycol
ferrosoferric oxide
FD&C Green No. 3
FD&C Yellow No. 6
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63739-0265 McKesson Packaging Services
00904-6136 Major Pharmaceuticals
16590-0781 Stat RX USA LLC (repackager)
43063-0196 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)